Skip to main content

Table 1 Comparison of the mean levels of s-IgA and s-amylase with oral/dental manifestations among the three studied groups

From: Association of salivary levels of immunoglobulin-a and amylase with oral-dental manifestations in patients with controlled and non-controlled type 2 diabetes

Oral/dental manifestations

s-IgA

s-Amylase

uncontrolled diabetic

controlled diabetic

control

p-value

uncontrolled diabetic

controlled diabetic

control

p-value

Oral candidiasis

195.79 ± 17.78

98.13 ± 10.67*

107.52 ± 32.69

0.002

193,364.67 ± 36,135.98

48,719.37 ± 28372*

42,078.33 ± 30,461.78

0.018

White plaque

210.76 ± 13.12

81.83 ± 22.68

–

0.013

307,490 ± 175,903.1

17,760.5 ± 1239.5

–

0.292

Erythematous candidiasis

209.88 ± 49.64

110.26 ± 23.2

–

0.436

216,400 ± 23,950.4

25,150 ± 2361.5

–

0.038

Thrush

221.85 ± 33.63

73.35 ± 6.73*

172.85 ± 8.3

0.57

136,500 ± 26,513.61

138,037 ± 108,821

12,035 ± 8651

0.254

Median rhomboid glossitis

163.13 ± 50.12

121.48 ± 16.93

74.85 ± 2.24

0.215

93,200 ± 37,900

17,670 ± 3452.91

57,100 ± 18,338.8

0.257

abscesses

221.98 ± 39.76

77.84 ± 23.19

–

0.022

284,466.66 ± 76,543.8

100,500 ± 53,700

0.243

0.243

Xerostomia

205.7 ± 20.87

81.75 ± 12.1*

118.49 ± 33.96

0.0001

189,807.6 ± 44,143.3

59,417.2 ± 2463.08

77,973.3 ± 26,897.8

0.065

  1. s-IgA, salivary immunoglobulin A; s-amylase, salivary amylase. * Significant difference with uncontrolled diabetes (P<0.05). Significant at <0.05 levels